MNKD.US's stock price is influenced by several factors: Company Performance: MannKind's revenue, earnings, and pipeline progress directly impact investor sentiment.

Afrezza Sales: Sales figures for Afrezza, their primary product, are a key driver of the stock's valuation. Positive sales growth often leads to price increases.

Clinical Trial Results: Results from any clinical trials for new or existing products can significantly affect the stock price, particularly if they show positive efficacy or safety.

Regulatory Approvals: FDA approvals for new indications or products are major catalysts for price appreciation.

Partnerships/Collaborations: Partnerships with other pharmaceutical companies can provide financial resources and validation of MannKind's technology, affecting the stock.

Market Conditions: Broader market trends, economic conditions, and the performance of the biotechnology sector can influence MNKD's stock price.

Competition: Competition from other diabetes treatments can impact Afrezza's market share and profitability, affecting the stock.

Investor Sentiment: General investor optimism or pessimism towards MannKind and its prospects plays a significant role.

News & Events: News releases, presentations, and other events related to MannKind can cause fluctuations in the stock price.

Debt Levels: MannKind's debt and financial stability are crucial factors for investors.